Danish procurers hail 87% Humira discount

Amgros, Denmark’s centralised procurement body for public hospitals, expects to realise a saving of almost 87% over the current price of Humira (adalimumab) following the advent of multisource biosimilar competition through a tender. The country’s medical council has just given the green light to substitute the autoimmune diseases treatment.